Dabigatran Etexilate
1160.283
Approved small_molecule active
Quick answer
Dabigatran Etexilate for Atrial Fibrillation is a Approved program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Atrial Fibrillation
- Phase
- Approved
- Modality
- small_molecule
- Status
- active